Cargando…

Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types

BACKGROUND: Solute Carrier Family 31 Member 1 (SLC31A1) has recently been identified as a cuproptosis-regulatory gene. Recent studies have indicated that SLC31A1 may play a role in colorectal and lung cancer tumorigenesis. However, the role of SLC31A1 and its cuproptosis-regulatory functions in mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Fan-Sheng, Ren, Chun-Yan, Jia, Ruofan, Zhou, Yuan, Chen, Jian-Huan, Ma, Yaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041742/ https://www.ncbi.nlm.nih.gov/pubmed/36973786 http://dx.doi.org/10.1186/s12920-023-01489-9

Ejemplares similares

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer
por: Zhang, Pei, et al.
Publicado: (2023)

Systematic pan-cancer analysis identifies SLC35C1 as an immunological and prognostic biomarker
por: Xie, Mingchen, et al.
Publicado: (2023)

Transcriptome analysis identification of A-to-I RNA editing in granulosa cells associated with PCOS
por: Kong, Fan-Sheng, et al.
Publicado: (2023)

Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
por: Jiang, Shan, et al.
Publicado: (2023)

Pan-Cancer Analysis Identified C1ORF112 as a Potential Biomarker for Multiple Tumor Types
por: Chen, Jiaxuan, et al.
Publicado: (2021)

Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene SLC7A11 as a Prognostic Biomarker for Cancer
por: Lin, Yi, et al.
Publicado: (2022)

A pan-cancer analysis of SLC1A5 in human cancers
por: Ni, Juan, et al.
Publicado: (2023)

Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Zheng, Haosheng, et al.
Publicado: (2022)

Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy
por: Li, Ya-Dong, et al.
Publicado: (2023)

Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer
por: Sun, Xiaonan, et al.
Publicado: (2023)

Comprehensive analysis of pan-cancer reveals the potential of SLC16A1 as a prognostic and immunological biomarker
por: Chen, Lingyun, et al.
Publicado: (2023)

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
por: Jiang, Tao, et al.
Publicado: (2020)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis
por: Chen, Peng, et al.
Publicado: (2023)

A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity
por: Jiang, Yi, et al.
Publicado: (2021)

SLC17A9 expression levels in a pan‑cancer panel and validation of the role of SLC17A9 as a novel prognostic biomarker for osteosarcoma
por: Li, Junqing, et al.
Publicado: (2023)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer
por: Chen, Xiaowei, et al.
Publicado: (2023)

Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
por: Bi, Guoshu, et al.
Publicado: (2021)

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
por: Yang, Yaqi, et al.
Publicado: (2022)

Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma
por: Wang, Jun, et al.
Publicado: (2023)

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer
por: Wang, Yuhang, et al.
Publicado: (2023)

A pan-cancer analysis revealed the role of the SLC16 family in cancer
por: Li, Jun, et al.
Publicado: (2021)

Pan-cancer analyses reveal GTSE1 as a biomarker for the immunosuppressive tumor microenvironment
por: Tan, Ke, et al.
Publicado: (2023)

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types
por: Hu, Ankang, et al.
Publicado: (2022)

Blockage of SLC31A1‐dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death
por: Yu, Ze, et al.
Publicado: (2019)

Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
por: Schwartz, Gregory W., et al.
Publicado: (2018)

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
por: Fäldt Beding, Anna, et al.
Publicado: (2022)

Hypoxia–Immune-Related Gene SLC19A1 Serves as a Potential Biomarker for Prognosis in Multiple Myeloma
por: Li, Wenjin, et al.
Publicado: (2022)

A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer
por: Liu, Jun, et al.
Publicado: (2021)

Pan-Cancer Analysis of the COVID-19 Causal Gene SLC6A20
por: Acar, Ahmet
Publicado: (2023)

A SLC31A1-MEK-DNMT1-miR-124 feedback loop contributes to pancreatic cancer progression
por: Jin, Jing, et al.
Publicado: (2022)

Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment
por: Lv, Jingfang, et al.
Publicado: (2023)

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022)

Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
por: Zhang, Rui, et al.
Publicado: (2022)

Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma
por: Xu, Lei, et al.
Publicado: (2022)

Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker
por: Chen, Peng, et al.
Publicado: (2023)

A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker
por: HUANG, YANGQING, et al.
Publicado: (2023)

Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters
por: Chevalier, Benoît, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gm9ddjqi5o7f87srcsd3grfor9